Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Vappu Marianna
VM
Rantalaiho
Hannu
H
Kautiainen
Markku
M
Korpela
Pekka J
PJ
Hannonen
Marjatta
M
Leirisalo-Repo
Timo
T
Möttönen
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D012460:Sulfasalazine / Q000627:therapeutic use*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D008727:Methotrexate